Related references
Note: Only part of the references are listed.In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification
Yu Wang et al.
BLOOD (2014)
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation
J-H Yoon et al.
BONE MARROW TRANSPLANTATION (2014)
Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: A comprehensive large-scale study from a single Chinese center
Ya-Zhen Qin et al.
LEUKEMIA RESEARCH (2014)
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement
Hee-Jin Kim et al.
ANNALS OF HEMATOLOGY (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
Anthony J. Bench et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Therapeutic targeting of c-KIT in cancer
Leonie K. Ashman et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
C. Allen et al.
LEUKEMIA (2013)
Mutant Enrichment with 3′-Modified Oligonucleotides A Practical PCR Method for Detecting Trace Mutant DNAs
Seung-Tae Lee et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia
S. Wakita et al.
LEUKEMIA (2011)
Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia
Sang Hyuk Park et al.
LEUKEMIA RESEARCH (2011)
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML
Jessica A. Pollard et al.
BLOOD (2010)
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation:: models for the 'second hit' hypothesis
H. Becker et al.
LEUKEMIA (2008)
Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples
L-Y Shih et al.
LEUKEMIA (2008)
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi et al.
BLOOD (2007)
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21):: A Cancer and Leukemia Group B study
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
N. Boissel et al.
LEUKEMIA (2006)
Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study
R Cairoli et al.
BLOOD (2006)
AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia:: Implication in stepwise leukemogenesis and response to Gleevec
YY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia:: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse
LY Shih et al.
BLOOD (2002)
Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia
S Meshinchi et al.
BLOOD (2001)
Share Paper
